Yunkai Yu Selected Research

Yunkai Yu Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 10/2008
4	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2017
3	Carcinoma (Carcinomatosis) 01/2024 - 01/2017
3	Disease Progression 01/2022 - 02/2014
3	Inflammation (Inflammations) 01/2019 - 06/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 07/2022
2	Adenocarcinoma 01/2024 - 07/2022
2	Infections 01/2022 - 02/2004
2	Malignant Mesothelioma 01/2018 - 01/2018
2	Mesothelioma 01/2018 - 11/2012
2	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 01/2008
2	Rhabdomyosarcoma 05/2011 - 10/2008
1	Cystadenocarcinoma 01/2024
1	Cholangiocarcinoma 01/2024
1	Capillary Leak Syndrome 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Fatigue 12/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Bronchiolitis Obliterans Syndrome 12/2021
1	Aberrant Crypt Foci 09/2021
1	Carcinogenesis 09/2021
1	Apnea 01/2021
1	Epistaxis (Nosebleed) 08/2017
1	Hypoxia (Hypoxemia) 08/2017
1	Hepatocellular Carcinoma (Hepatoma) 08/2017
1	Adenocarcinoma of Lung 06/2017
1	Circulating Neoplastic Cells 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2015
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2014
1	Respiratory Insufficiency (Respiratory Failure) 02/2014
1	Weight Loss (Weight Reduction) 02/2014
1	Pain (Aches) 02/2014
1	Thymoma (Thymic Carcinoma) 02/2014
1	Lymphoma (Lymphomas) 05/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2011
1	Alveolar Rhabdomyosarcoma 08/2010
1	Residual Neoplasm 06/2010
1	Osteosarcoma (Osteogenic Sarcoma) 06/2010

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2008
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2010
4	MesothelinIBA 01/2024 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2017
3	carotuximabIBA 08/2017 - 10/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 03/2011
3	EndoglinIBA 08/2017 - 10/2015
3	Sorafenib (BAY 43-9006)FDA Link 08/2017 - 01/2008
2	Immunotoxins (Immunotoxin)IBA 01/2024 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2012
2	CytokinesIBA 12/2021 - 06/2017
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2017 - 11/2012
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 09/2015 - 05/2011
2	Caspase 8 (Caspase-8)IBA 09/2015 - 05/2011
2	cixutumumabIBA 02/2014 - 11/2012
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2012 - 10/2008
1	tofacitinibIBA 01/2024
1	AntibodiesIBA 01/2024
1	LMB-100IBA 01/2024
1	ExotoxinsIBA 01/2024
1	Doxycycline (Periostat)FDA LinkGeneric 07/2022
1	CollagenIBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 07/2022
1	cabozantinibIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 12/2021
1	SeleniumIBA 09/2021
1	Selenoproteins (Selenoprotein)IBA 09/2021
1	AzoxymethaneIBA 09/2021
1	MucinsIBA 09/2021
1	Dextran SulfateIBA 09/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Monocyte Chemoattractant ProteinsIBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Chemokine CCL3IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	InterferonsIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 08/2017
1	Indicators and Reagents (Reagents)IBA 06/2017
1	OsteopontinIBA 01/2017
1	Lipase (Acid Lipase)FDA Link 02/2014
1	Insulin (Novolin)FDA Link 11/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2012
1	TriterpenesIBA 02/2012
1	AcidsIBA 02/2012
1	bardoxoloneIBA 02/2012
1	drozitumabIBA 05/2011
1	Epidermal Growth Factor (EGF)IBA 05/2011
1	Bevacizumab (Avastin)FDA Link 05/2011
1	vandetanib (ZD6474)IBA 05/2011
1	MTOR InhibitorsIBA 06/2010

Therapy/Procedure

6	Therapeutics 07/2022 - 10/2008
1	Wearable Electronic Devices 01/2021
1	Castration 10/2015
1	Drug Therapy (Chemotherapy) 09/2015
1	Treatment Delay 11/2012